The estimated Net Worth of William A Osborn is at least $37.1 Milione dollars as of 26 October 2021. Mr. Osborn owns over 15,752 units of Abbott Laboratories stock worth over $11,309,734 and over the last 18 years he sold ABT stock worth over $25,430,450. In addition, he makes $330,910 as Lead Independent Director at Abbott Laboratories.
Sign up
Mr. Osborn ABT stock SEC Form 4 insiders trading
William has made over 58 trades of the Abbott Laboratories stock since 2007, according to the Form 4 filled with the SEC. Most recently he exercised 15,752 units of ABT stock worth $935,984 on 26 October 2021.
The largest trade he's ever made was exercising 63,969 units of Abbott Laboratories stock on 18 April 2008 worth over $2,657,912. On average, William trades about 8,199 units every 30 days since 2006. As of 26 October 2021 he still owns at least 96,996 units of Abbott Laboratories stock.
You can see the complete history of Mr. Osborn stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
William Osborn biography
William A. (Bill) Osborn serves as Lead Independent Director of the Company. Mr. Osborn was Chairman of Northern Trust Corporation from 1995 through 2009 and served as its Chief Executive Officer from 1995 through 2007. Mr. Osborn currently serves as a Director of Caterpillar Inc. and General Dynamics Corporation. Mr. Osborn served on the Board of Directors of Nicor, Inc. from 1999 to 2006 and on the Board of Directors of Tribune Company from 2001 to 2012. As the Chairman and Chief Executive Officer of Northern Trust Corporation and The Northern Trust Company, Mr. Osborn acquired broad experience in successfully overseeing complex global businesses operating in highly regulated industries.
What is the salary of William Osborn?
As the Lead Independent Director of Abbott Laboratories, the total compensation of William Osborn at Abbott Laboratories is $330,910. There are 16 executives at Abbott Laboratories getting paid more, with Miles White having the highest compensation of $27,802,800.
How old is William Osborn?
William Osborn is 72, he's been the Lead Independent Director of Abbott Laboratories since 2013. There are 2 older and 41 younger executives at Abbott Laboratories. The oldest executive at Abbott Laboratories is Samuel Scott, 75, who is the Independent Director.
What's William Osborn's mailing address?
William's mailing address filed with the SEC is 100 ABBOTT PARK ROAD, , ABBOTT PARK, IL, 60064.
Insiders trading at Abbott Laboratories
Over the last 24 years, insiders at Abbott Laboratories have traded over $388,257,551 worth of Abbott Laboratories stock and bought 1,028,477 units worth $44,923,618 . The most active insiders traders include Miles D White, Richard A Gonzalez e Jeffrey M Leiden. On average, Abbott Laboratories executives and independent directors trade stock every 9 days with the average trade being worth of $4,003,344. The most recent stock trade was executed by John A. Jr. Mccoy on 1 September 2024, trading 27 units of ABT stock currently worth $3,100.
What does Abbott Laboratories do?
Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States.
What does Abbott Laboratories's logo look like?
Complete history of Mr. Osborn stock trades at Northern Trust, Abbott Laboratories, Caterpillar e General Dynamics
Abbott Laboratories executives and stock owners
Abbott Laboratories executives and other stock owners filed with the SEC include:
-
Miles White,
Executive Chairman of the Board -
Robert Ford,
President, Chief Executive Officer, Director -
Lisa Earnhardt,
Executive Vice President - Medical Devices -
Hubert Allen,
Executive Vice President, General Counsel, Secretary -
Miles D. White M.B.A.,
Exec. Chairman -
Daniel Salvadori,
Executive Vice President - Nutritional Products -
Robert B. Ford,
Chairman, Pres & CEO -
John Capek,
Executive Vice President - Ventures -
Robert E. Funck Jr.,
Exec. VP of Fin. & CFO -
Hubert L. Allen,
Exec. VP, Gen. Counsel & Sec. -
Daniel Gesua Sive Salvadori,
Exec. VP and Group Pres of Established Pharmaceuticals & Nutritional Products -
John F. Ginascol,
Exec. VP of Core Diagnostics -
Robert Alpern,
Independent Director -
Sally Blount,
Independent Director -
Glenn Tilton,
Independent Director -
Samuel Scott,
Independent Director -
William Osborn,
Lead Independent Director -
Roxanne Austin,
Independent Director -
Edward Liddy,
Independent Director -
Phebe Novakovic,
Independent Director -
Nancy McKinstry,
Independent Director -
Michelle Kumbier,
Independent Director -
John Stratton,
Independent Director -
Daniel Starks,
Independent Director -
Darren McDew,
Independent Director -
Randel Woodgrift,
Senior Vice President - CRM -
Alejandro Wellisch,
Senior Vice President - Established Pharmaceuticals, Latin America -
Jared Watkin,
Senior Vice President - Diabetes Care -
Christopher Scoggins,
Senior Vice President - Rapid Diagnostics -
Michael Pederson,
Senior Vice President - Electrophysiology and Heart Failure -
Joseph Manning,
Senior Vice President - Nutrition International -
Sammy Karam,
Senior Vice President - Established Pharmaceuticals, Emerging Markets -
Michael Dale,
Senior Vice President - Structural Heart -
Jaime Contreras,
Senior Vice President - Core Laboratory Diagnostics, Commercial Operations -
Charles Brynelsen,
Senior Vice President - Abbott Vascular -
Roger Bird,
Senior Vice President - U.S. Nutrition -
Andrea Wainer,
Executive Vice President - Rapid and Molecular Diagnostics -
Andrew Lane,
Executive Vice President - Established Pharmaceuticals -
John Ginascol,
Executive Vice President - Core Diagnostics -
Mary Moreland,
Executive Vice President of Human Resources -
Robert Funck,
Chief Financial Officer, Executive Vice President - Finance -
Gregory A. Ahlberg,
Sr. VP of Core Laboratory Diagnostics & Commercial Operations -
Elaine R. Leavenworth,
Sr. VP and Chief Marketing & External Affairs Officer -
Melissa Brotz,
VP of Public Affairs & Corp. Marketing -
James E. Young,
VP and Chief Ethics & Compliance Officer -
Scott Michael Leinenweber,
VP of Investor Relations, Licensing & Acquisitions -
Sean Shrimpton,
Senior Vice President -
Deepak S. Nath,
Senior Vice President -
Brian B Yoor,
Executive Vice President & CFO -
Brian J Blaser,
Senior Vice President -
Stephen R Fussell,
Senior Vice President -
Michael J Warmuth,
Senior Vice President -
Eric S Fain,
Senior Vice President -
Sharon J Bracken,
Senior Vice President -
Michael T Rousseau,
Pres., Cardiovasc. & Neuromod. -
Richard W Ashley,
Executive Vice President -
Christopher J. Calamari,
SENIOR VICE PRESIDENT -
Julie L. Tyler,
SENIOR VICE PRESIDENT -
Jean Yves Pavee,
Senior Vice President -
W James Farrell,
Director -
Thomas C Freyman,
Senior Vice President -
Georges H. De Vos,
Senior Vice President -
Katherine C. Doyle,
Senior Vice President -
J. Scott White,
Senior Vice President -
Charles D Foltz,
Senior Vice President -
Murthy V Simhambhatla,
Senior Vice President -
Thomas G Frinzi,
Senior Vice President -
John C Landgraf,
Senior Vice President -
Greg W Linder,
Vice President -
Heather L Mason,
Senior Vice President -
Paul K Magill,
Senior Vice President -
A. David Forrest,
Senior Vice President -
H Laurance Fuller,
Director -
Carlos Alban,
Senior Vice President -
James V Mazzo,
Senior Vice President -
Holger A Liepmann,
Senior Vice President -
William D Smithburg,
Director -
Laura J Schumacher,
Senior Vice President -
David Owen,
Director -
Edward L. Michael,
Senior Vice President -
Richard A Gonzalez,
Chief Operating Officer -
Donald V Jr Patton,
Senior Vice President -
William M Daley,
Director -
Robert B Hance,
Senior Vice President -
Mary T Szela,
Senior Vice President -
Roy S Roberts,
Director -
Corlis D Murray,
Senior Vice President -
Thomas F Chen,
Senior Vice President -
Olivier Bohuon,
Senior Vice President -
James L Tyree,
Senior Vice President -
W Ann Reynolds,
Director -
Boone Jr Powell,
Director -
Edward J Fiorentino,
Senior Vice President -
Gary E Mccullough,
Senior Vice President -
Jeffrey M Leiden,
President & COO -
Jack M Greenberg,
Director -
Joseph M Nemmers,
Senior Vice President -
John R Walter,
Director -
Jeffrey R Binder,
Senior Vice President -
William G Dempsey,
Senior Vice President -
A Barry Rand,
Director -
Thomas M Wascoe,
Senior Vice President -
Christopher B Begley,
Senior Vice President -
Lance B Wyatt,
Senior Vice President -
Guillermo A Herrera,
Senior Vice President -
Lasa Jose M De,
Senior Vice President -
Fernando Mateus,
SENIOR VICE PRESIDENT -
Gregory A Ahlberg,
SENIOR VICE PRESIDENT -
John A. Jr. Mccoy,
VICE PRESIDENT -
Philip P Boudreau,
EXECUTIVE VICE PRESIDENT -
Claire Babineaux Fontenot,
-
Michael O'grady,
-
Louis H. Morrone,
EXECUTIVE VICE PRESIDENT -
Patricia Paola Gonzalez,
-
Michael F Roman,